Literature DB >> 31296301

The airway epithelium in asthma.

Luke R Bonser1, David J Erle2.   

Abstract

Asthma is a genetically and phenotypically complex disease that has a major impact on global health. Signs and symptoms of asthma are caused by the obstruction of airflow through the airways. The epithelium that lines the airways plays a major role in maintaining airway patency and in host defense. The epithelium initiates responses to inhaled or aspirated substances, including allergens, viruses, and bacteria, and epithelial-derived cytokines are important in the recruitment and activation of immune cells in the airway. Changes in the structure and function of the airway epithelium are a prominent feature of asthma. Approximately half of individuals with asthma have evidence of active type 2 immune responses in the airway. In these individuals, epithelial cytokines promote type 2 responses, and responses to type 2 cytokines result in increased epithelial mucus production and other effects that cause airway obstruction. Recent work also implicates other epithelial responses, including interleukin-17, interferon and ER stress responses, that may contribute to asthma pathogenesis and provide new targets for therapy.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Airway epithelium; Alarmins; Asthma; Endoplasmic reticulum stress; Endotype; IL-13; IL-17; Interferon; Mucus; Type 2-high asthma

Mesh:

Substances:

Year:  2019        PMID: 31296301     DOI: 10.1016/bs.ai.2019.05.001

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  11 in total

1.  Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets.

Authors:  Luke R Bonser; Kyung Duk Koh; Kristina Johansson; Semil P Choksi; Dan Cheng; Leqian Liu; Dingyuan I Sun; Lorna T Zlock; Walter L Eckalbar; Walter E Finkbeiner; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 2.  The airway epithelium during infancy and childhood: A complex multicellular immune barrier. Basic review for clinicians.

Authors:  Xilei Xu-Chen; Jered Weinstock; Deepa Rastogi; Anastassios Koumbourlis; Gustavo Nino
Journal:  Paediatr Respir Rev       Date:  2021-04-22       Impact factor: 2.726

Review 3.  Cell-Specific DNA Methylation Signatures in Asthma.

Authors:  Andrée-Anne Hudon Thibeault; Catherine Laprise
Journal:  Genes (Basel)       Date:  2019-11-15       Impact factor: 4.096

4.  IL-17C expression and its correlation with pediatric adenoids: a preliminary study.

Authors:  Hyun Jin Min; Kyung Soo Kim
Journal:  Int J Med Sci       Date:  2020-09-20       Impact factor: 3.738

Review 5.  Lung organoids, useful tools for investigating epithelial repair after lung injury.

Authors:  Jing Kong; Shiyuan Wen; Wenjing Cao; Peng Yue; Xin Xu; Yu Zhang; Lisha Luo; Taigui Chen; Lianbao Li; Feng Wang; Jian Tao; Guozhong Zhou; Suyi Luo; Aihua Liu; Fukai Bao
Journal:  Stem Cell Res Ther       Date:  2021-01-30       Impact factor: 6.832

6.  Exploration of induced sputum BIRC3 levels and clinical implications in asthma.

Authors:  Lijuan Du; Changyi Xu; Zhimin Zeng; Fengjia Chen; Kun Tang; Yuxia Liang; Yubiao Guo
Journal:  BMC Pulm Med       Date:  2022-03-14       Impact factor: 3.317

7.  Gypenoside A from Gynostemma pentaphyllum Attenuates Airway Inflammation and Th2 Cell Activities in a Murine Asthma Model.

Authors:  Wen-Chung Huang; Shu-Ju Wu; Kuo-Wei Yeh; Chian-Jiun Liou
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

8.  The Pioneer Transcription Factor Foxa2 Modulates T Helper Differentiation to Reduce Mouse Allergic Airway Disease.

Authors:  Diana C Yánez; Ching-In Lau; Eleftheria Papaioannou; Mira M Chawda; Jasmine Rowell; Susan Ross; Anna Furmanski; Tessa Crompton
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

Review 9.  Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases.

Authors:  Yvonne Janssen-Heininger; Niki L Reynaert; Albert van der Vliet; Vikas Anathy
Journal:  Redox Biol       Date:  2020-03-23       Impact factor: 11.799

10.  Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes.

Authors:  Charlene M Prazma; Marco Idzko; Jo Anne Douglass; Arnaud Bourdin; Stephen Mallett; Frank C Albers; Steven W Yancey
Journal:  J Asthma Allergy       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.